Task: Answer the multiple-choice question.
Query: Which drug exhibits a 13.451\% hERG inhibition at 1uM?
Constraint: You must select none, one or more options from a, b, or c without using any other words.
Options:
a: CC(=O)C(Cc1cccc(F)c1)(Cc1cccc(F)c1)C(C)=O
b: CCCC(=O)NC(=S)Nc1cccc(NC(=O)c2ccccc2Cl)c1
c: Nc1c(C(=O)Nc2ccccc2)sc2nc3c(c(-c4ccco4)c12)CCC3
Answer: b. CCCC(=O)NC(=S)Nc1cccc(NC(=O)c2ccccc2Cl)c1
{#Task|Problem statement!}: Answer the {#multiple choice|multiple-choice|MCQ!} question.
{#Question|Query!}: Which {#compound|drug!} {#has|exhibits!} a {herg_central_at_1uM#}{herg_central_at_1uM__units} {herg_central_at_1uM__names__noun}?
Constraint: You must select none, one or more options from {%multiple_choice_enum%2-5%aA1} without using any {#other|additional!} words.
Options:
{SMILES%herg_central_at_1uM%}
Answer: {%multiple_choice_result}. {SMILES#}
CCCC(=O)NC(=S)Nc1cccc(NC(=O)c2ccccc2Cl)c1
CCCC(=O)NC(=S)Nc1cccc(NC(=O)c2ccccc2Cl)c1
N-[3-(butanoylcarbamothioylamino)phenyl]-2-chlorobenzamide